-
www.uspreventiveservicestaskforce.org/uspstf/document/RecommendationStatementFinal/breast-cancer-screening
April 30, 2024 - Share to Facebook
Share to X
Share to WhatsApp
Share to Email
Print
Final Recommendation Statement
Breast Cancer: Screening
April 30, 2024
Recommendations made by the USPSTF are independent of the U.S. government. They should not be constru…
-
www.uspreventiveservicestaskforce.org/home/getfilebytoken/TYPA75a_t7HaJeDhWqCJ9n
August 13, 2019 - Two
reviewers independently assessed the methodological quality of eli-
gible studies using design-specific … sizes were small and estimates imprecise. … Across 45 prospective cohort studies on diagnostic accuracy,
mean sample size was 500 (range, 42-24 854 … Mean sample size was 326 (range, 21-1000), mean
age was 29.2 years (range, 26.3-32.6), and mean BMI was … Concept and design: Pillay, Donovan, Chou,
Hartling.
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/tonsillectomy_executive.pdf
January 01, 2017 - postoperative (discharge from postanesthesia care to up to 10 days postsurgery) agent for pain (KQ6)
Design … Extraction and Synthesis
We extracted data from included studies into templates that
recorded study design … Individual Studies in Systematic Reviews of Health Care
Interventions11) appropriate to each study design
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/gestational-diabetes-screening-diagnosis_executive.pdf
October 01, 2012 - and
specificity.50 For the other Key Questions, we combined
studies in a meta-analysis if the study design … methodological quality was assessed using different
tools depending on the Key Question and study design … find a statistically
significant difference in pregnancy outcomes appears
more dependent on study design … Differences may have also resulted due to study
design: in the ACHOIS trial, participants did not receive
-
effectivehealthcare.ahrq.gov/sites/default/files/s66.pdf
October 01, 2007 - Strict selection criteria limit generalization of results13; most
trials are of short duration3; and sample … size constraints limit
their ability to identify infrequent adverse effects.12–14 Fi-
nally, the experimental … Using a large cohort of Medicaid enrollees with RA, we
applied a new user design to compare measurements
-
effectivehealthcare.ahrq.gov/sites/default/files/cer-243-prehospital-airway-management-appendix-e-1_0.xlsx
January 01, 2020 - Author, Year Year KQ 1
BVM vs SGA KQ 2
BVM vs ETI KQ 3
SGA vs ETI KQ4
Variations of Single Airway Study Design … Emergency Type Prehospital Provider Study Level P+P155rovider Group Mode of Transport Eligibility Criteria Sample … Size % Female Age
Mean (SD) Race/Ethnicity Funding Source Risk of Bias
Arima, 2014 2014 0 0 0 ETI
-
integrationacademy.ahrq.gov/sites/default/files/2025-07/MOUD_Playbook_Environmental_Scan_2025.pdf
January 01, 2025 - a Barrier to Care............................................................................. 33
Design … oud-low-threshold-treatment
Delivering Medications for Opioid Use Disorder in Primary Care: Environmental Scan 34
Design … Crisis
Refocus the Playbook to Promote Low-Threshold Care
Address Stigma as a Barrier to Care
Design
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/insulin-blood-sugar-2010_executive.pdf
January 01, 2010 - Adults With Type 1 Diabetes
Study Design. … Adults With Type 2 Diabetes
Study Design. … Pregnant Women With Pre-Existing Type 1 Diabetes
Study Design. … Study Design. … All studies targeted type 1 diabetes and
most studies had small sample sizes.
Outcomes.
-
integrationacademy.ahrq.gov/sites/default/files/2025-06/Innovations%20in%20Behavioral%20Health%20Integration_Transcript.docx
January 01, 2025 - the Moud treatment.
71
00:15:59.750 --> 00:16:26.929
Anna Ratzliff (she/her): So this is the basic design … In other words, because the design of the trial was an intent to treat design.
-
hcup-us.ahrq.gov/db/nation/nis/APS-DRGs%20V22%20Definitions%20Manual.pdf
April 01, 2006 - ___APS-Def_Public.book
2 3 2 1 W h i t n e y A v e n u e • H a m d e n , C T 0 6 5 1 8 • 1 - 8 0 0 - 9 9 9 - 3 7 4 7
D e f i n i t i o n s M a n u a l
APS-DRGs
ALL-PAYER SEVERITY-ADJUSTED DRG
(APS-DRGS®) ASSIGNMENT
FOR PUBLIC USE
VERSION 22
®
PUB 4.5.2006
COPYRIGHT PAGE
Copyright © 2006 HSS Inc.
A…
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/asthma-immunotherapy-2010_executive.pdf
January 01, 2010 - SCIT: 8
Excluded
1,626
Reasons for Exclusion at Article Review Level*
• Abstract only: 45
• Study design … The
majority of studies had a moderate risk of bias due to the
design choices that were made. … Most of the studies had small sample
sizes; so, relevant statistical information on continuous
outcomes … The RCTs should be
conducted with attention to the design elements that
reduce bias, such as clear … How to design
and evaluate randomized controlled trials in immunotherapy for
allergic rhinitis: an
-
www.uspreventiveservicestaskforce.org/uspstf/recommendation/hiv-sexually-transmitted-diseases-behavioral-counseling-1996
January 01, 1996 - number of persons injecting drugs or the frequency of drug use. 65 , 66 Due to difficulties in study design
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/type-2-diabetes-medications-update_surveillance.pdf
December 31, 2013 - comparisons were included for the
outcome of neuropathy, but studies were at
high risk for bias, with low sample … sizes and
poorly defined outcomes. … Evidence Table
Author,
Year Intervention Comparator(s)
Study
Design N, Population Duration
Primary … comparisons were included for the outcome of neuropathy, but
studies were at high risk for bias, with low sample … sizes and poorly
defined outcomes.
-
www.uspreventiveservicestaskforce.org/home/getfilebytoken/B_Ae7DdLL7DNauBLXC-ptu
June 01, 2003 - Staff of the
funding agency and members of the USPSTF
contributed to the study design, reviewed draft … One RCT
with a crossover design showed that 6 weeks of
therapy with clomipramine (a tricyclic antidepressant
-
effectivehealthcare.ahrq.gov/sites/default/files/c-difficile-update_disposition-comments.pdf
March 29, 2016 - Disposition of Comments for CER 172 Clostridium Difficile Diagnosis Prevention Treatment
Comparative Effectiveness Review Disposition of Comments Report
Research Review Title: Early Diagnosis, Prevention, and Treatment of Clostridium difficile:
Update
Draft review available for public comment from April 20, 2015…
-
www.uspreventiveservicestaskforce.org/home/getfilebytoken/zmvjborz6pkcGVzgcP5nCw
September 30, 2024 - Screening for Breast Cancer: US Preventive Services Task Force Recommendation Statement
Screening for Breast Cancer
US Preventive Services Task Force Recommendation Statement
US Preventive Services Task Force
Summary of Recommendations
See the Summary of Recommendations figure.
IMPORTANCE Among all US women, breas…
-
www.uspreventiveservicestaskforce.org/uspstf/recommendation/breast-cancer-screening
April 30, 2024 - Share to Facebook
Share to X
Share to WhatsApp
Share to Email
Print
Final Recommendation Statement
Breast Cancer: Screening
April 30, 2024
Recommendations made by the USPSTF are independent of the U.S. government. They should not be con…
-
www.ahrq.gov/research/findings/nhqrdr/chartbooks/healthyliving/healthyliving-slides.html
April 01, 2018 - Numbers of measures differ across groups because of sample size limitations. … Number of measures differs across groups because of sample size limitations.
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/health-systems-research.pdf
October 01, 2017 - Understanding Health-Systems’ Use of and Need for Evidence To Inform Decisionmaking
White Paper
Understanding Health-Systems’ Use of and
Need for Evidence To Inform Decisionmaking
Research White Paper
Understanding Health-Systems’ Use of and
Need for Evidence To Inform Decisionmaking
Prepared for:
Agency …
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cancer-survivor-care-transition_disposition-comments.pdf
March 18, 2014 - Study design is a key issue
here, with unique models of care emerging at
different institutions. … The section on design characteristics
should summarize the level of the intervention
and comparison … GQ3, excellent points about
the lack of research done, the heterogeneity of
models, and the study design … Efforts to
design and evaluate survivorship care models
must have assessment of
outcomes/endpoints